Relmada Therapeutics (4E2.F) Q1 2025 Earnings

Mar 27Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.79
-0.71
-0.62
-0.54

Details

Expected EPS
-0.62339862472
Actual EPS
-0.5740208
Surprise EPS
0.05
Surprise Percent
+7.92%

Description

⁨Relmada Therapeutics⁩ (⁦4E2.F⁩) has reported earnings of ⁦-0.5740208⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts